Global Diagnostic Radiopharmaceuticals Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Diagnostic Radiopharmaceuticals market size is predicted to grow from US$ 5283 million in 2025 to US$ 7998 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.
Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.
In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.
The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.
One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.
North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
LP Information, Inc. (LPI) ' newest research report, the “Diagnostic Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Diagnostic Radiopharmaceuticals sales in 2024, providing a comprehensive analysis by region and market sector of projected Diagnostic Radiopharmaceuticals sales for 2025 through 2031. With Diagnostic Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Radiopharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Diagnostic Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostic Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Radiopharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Diagnostic Radiopharmaceuticals market?
What factors are driving Diagnostic Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostic Radiopharmaceuticals market opportunities vary by end market size?
How does Diagnostic Radiopharmaceuticals break out by Type, by Application?
The global Diagnostic Radiopharmaceuticals market size is predicted to grow from US$ 5283 million in 2025 to US$ 7998 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.
Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.
In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.
The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.
One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.
North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
LP Information, Inc. (LPI) ' newest research report, the “Diagnostic Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Diagnostic Radiopharmaceuticals sales in 2024, providing a comprehensive analysis by region and market sector of projected Diagnostic Radiopharmaceuticals sales for 2025 through 2031. With Diagnostic Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Radiopharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Diagnostic Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostic Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Radiopharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Technetium 99
- Fluorine 18
- Other
- Oncology
- Cardiology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cardinal Health
- GE Healthcare
- Jubilant Pharma
- Novartis
- Curium Pharma
- SIEMENS
- Lantheus
- Bracco Imaging
- Eli Lilly
- China Isotope & Radiation
- Dongcheng
What is the 10-year outlook for the global Diagnostic Radiopharmaceuticals market?
What factors are driving Diagnostic Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostic Radiopharmaceuticals market opportunities vary by end market size?
How does Diagnostic Radiopharmaceuticals break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Diagnostic Radiopharmaceuticals by Country/Region, 2020, 2024 & 2031
2.2 Diagnostic Radiopharmaceuticals Segment by Type
2.2.1 Technetium
2.2.2 Fluorine
2.2.3 Other
2.3 Diagnostic Radiopharmaceuticals Sales by Type
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2020-2025)
2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2020-2025)
2.4 Diagnostic Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals Sales by Application
2.5.1 Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2020-2025)
2.5.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Application (2020-2025)
2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Diagnostic Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Company (2020-2025)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
3.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Company (2020-2025)
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals Product Location Distribution
3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Diagnostic Radiopharmaceuticals Market Size by Geographic Region (2020-2025)
4.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Diagnostic Radiopharmaceuticals Market Size by Country/Region (2020-2025)
4.2.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Country/Region (2020-2025)
4.2.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Country/Region (2020-2025)
4.3 Americas Diagnostic Radiopharmaceuticals Sales Growth
4.4 APAC Diagnostic Radiopharmaceuticals Sales Growth
4.5 Europe Diagnostic Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Diagnostic Radiopharmaceuticals Sales by Country
5.1.1 Americas Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
5.1.2 Americas Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025)
5.2 Americas Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
5.3 Americas Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals Sales by Region
6.1.1 APAC Diagnostic Radiopharmaceuticals Sales by Region (2020-2025)
6.1.2 APAC Diagnostic Radiopharmaceuticals Revenue by Region (2020-2025)
6.2 APAC Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
6.3 APAC Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Diagnostic Radiopharmaceuticals by Country
7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025)
7.2 Europe Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
7.3 Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
10.4 Industry Chain Structure of Diagnostic Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostic Radiopharmaceuticals Distributors
11.3 Diagnostic Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Diagnostic Radiopharmaceuticals Forecast by Region (2026-2031)
12.1.2 Global Diagnostic Radiopharmaceuticals Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Diagnostic Radiopharmaceuticals Forecast by Type (2026-2031)
12.7 Global Diagnostic Radiopharmaceuticals Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Cardinal Health
13.1.1 Cardinal Health Company Information
13.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Main Business Overview
13.1.5 Cardinal Health Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Jubilant Pharma
13.3.1 Jubilant Pharma Company Information
13.3.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jubilant Pharma Main Business Overview
13.3.5 Jubilant Pharma Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 SIEMENS
13.6.1 SIEMENS Company Information
13.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SIEMENS Main Business Overview
13.6.5 SIEMENS Latest Developments
13.7 Lantheus
13.7.1 Lantheus Company Information
13.7.2 Lantheus Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lantheus Main Business Overview
13.7.5 Lantheus Latest Developments
13.8 Bracco Imaging
13.8.1 Bracco Imaging Company Information
13.8.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bracco Imaging Main Business Overview
13.8.5 Bracco Imaging Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 China Isotope & Radiation
13.10.1 China Isotope & Radiation Company Information
13.10.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 China Isotope & Radiation Main Business Overview
13.10.5 China Isotope & Radiation Latest Developments
13.11 Dongcheng
13.11.1 Dongcheng Company Information
13.11.2 Dongcheng Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.11.3 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dongcheng Main Business Overview
13.11.5 Dongcheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTechnetium 99
Table 4. Major Players ofFluorine 18
Table 5. Major Players of Other
Table 6. Global Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 7. Global Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue byType (2020-2025) & ($ million)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue Market Share byType (2020-2025)
Table 10. Global Diagnostic Radiopharmaceuticals Sale Price byType (2020-2025) & (US$/Dose)
Table 11. Global Diagnostic Radiopharmaceuticals Sale by Application (2020-2025) & (K Dose)
Table 12. Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2020-2025)
Table 13. Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2025) & ($ million)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
Table 15. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2020-2025) & (US$/Dose)
Table 16. Global Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 18. Global Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 20. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2020-2025) & (US$/Dose)
Table 21. Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 22. Players Diagnostic Radiopharmaceuticals Products Offered
Table 23. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Diagnostic Radiopharmaceuticals Sales by Geographic Region (2020-2025) & (K Dose)
Table 27. Global Diagnostic Radiopharmaceuticals Sales Market Share Geographic Region (2020-2025)
Table 28. Global Diagnostic Radiopharmaceuticals Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Diagnostic Radiopharmaceuticals Sales by Country/Region (2020-2025) & (K Dose)
Table 31. Global Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2020-2025)
Table 32. Global Diagnostic Radiopharmaceuticals Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 35. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Table 36. Americas Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 38. Americas Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 39. APAC Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
Table 40. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. APAC Diagnostic Radiopharmaceuticals Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 43. APAC Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 44. Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 45. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 47. Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 48. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 49. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 51. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Diagnostic Radiopharmaceuticals
Table 53. Key Market Challenges & Risks of Diagnostic Radiopharmaceuticals
Table 54. Key IndustryTrends of Diagnostic Radiopharmaceuticals
Table 55. Diagnostic Radiopharmaceuticals Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Diagnostic Radiopharmaceuticals Distributors List
Table 58. Diagnostic Radiopharmaceuticals Customer List
Table 59. Global Diagnostic Radiopharmaceuticals SalesForecast by Region (2026-2031) & (K Dose)
Table 60. Global Diagnostic Radiopharmaceuticals RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Diagnostic Radiopharmaceuticals SalesForecast by Country (2026-2031) & (K Dose)
Table 62. Americas Diagnostic Radiopharmaceuticals Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Diagnostic Radiopharmaceuticals SalesForecast by Region (2026-2031) & (K Dose)
Table 64. APAC Diagnostic Radiopharmaceuticals Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Diagnostic Radiopharmaceuticals SalesForecast by Country (2026-2031) & (K Dose)
Table 66. Europe Diagnostic Radiopharmaceuticals RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Diagnostic Radiopharmaceuticals SalesForecast by Country (2026-2031) & (K Dose)
Table 68. Middle East & Africa Diagnostic Radiopharmaceuticals RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Diagnostic Radiopharmaceuticals SalesForecast byType (2026-2031) & (K Dose)
Table 70. Global Diagnostic Radiopharmaceuticals RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Diagnostic Radiopharmaceuticals SalesForecast by Application (2026-2031) & (K Dose)
Table 72. Global Diagnostic Radiopharmaceuticals RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Cardinal Health Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 74. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 75. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 76. Cardinal Health Main Business
Table 77. Cardinal Health Latest Developments
Table 78. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 80. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 81. GE Healthcare Main Business
Table 82. GE Healthcare Latest Developments
Table 83. Jubilant Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 85. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 86. Jubilant Pharma Main Business
Table 87. Jubilant Pharma Latest Developments
Table 88. Novartis Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Curium Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 96. Curium Pharma Main Business
Table 97. Curium Pharma Latest Developments
Table 98. SIEMENS Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 100. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 101. SIEMENS Main Business
Table 102. SIEMENS Latest Developments
Table 103. Lantheus Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Lantheus Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 106. Lantheus Main Business
Table 107. Lantheus Latest Developments
Table 108. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 111. Bracco Imaging Main Business
Table 112. Bracco Imaging Latest Developments
Table 113. Eli Lilly Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 115. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 116. Eli Lilly Main Business
Table 117. Eli Lilly Latest Developments
Table 118. China Isotope & Radiation Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 120. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 121. China Isotope & Radiation Main Business
Table 122. China Isotope & Radiation Latest Developments
Table 123. Dongcheng Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Dongcheng Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 125. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 126. Dongcheng Main Business
Table 127. Dongcheng Latest Developments
LIST OFFIGURES
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radiopharmaceuticals Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Diagnostic Radiopharmaceuticals Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2024)
Figure 10. Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTechnetium 99
Figure 12. Product Picture ofFluorine 18
Figure 13. Product Picture of Other
Figure 14. Global Diagnostic Radiopharmaceuticals Sales Market Share byType in 2025
Figure 15. Global Diagnostic Radiopharmaceuticals Revenue Market Share byType (2020-2025)
Figure 16. Diagnostic Radiopharmaceuticals Consumed in Oncology
Figure 17. Global Diagnostic Radiopharmaceuticals Market: Oncology (2020-2025) & (K Dose)
Figure 18. Diagnostic Radiopharmaceuticals Consumed in Cardiology
Figure 19. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2020-2025) & (K Dose)
Figure 20. Diagnostic Radiopharmaceuticals Consumed in Other
Figure 21. Global Diagnostic Radiopharmaceuticals Market: Other (2020-2025) & (K Dose)
Figure 22. Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2024)
Figure 23. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2025
Figure 24. Diagnostic Radiopharmaceuticals Sales by Company in 2025 (K Dose)
Figure 25. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2025
Figure 26. Diagnostic Radiopharmaceuticals Revenue by Company in 2025 ($ millions)
Figure 27. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2025
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 31. Americas Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 32. APAC Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 33. APAC Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 34. Europe Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 35. Europe Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 37. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 38. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 39. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 40. Americas Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 41. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 42. United States Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2025
Figure 47. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Figure 48. APAC Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 49. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 50. China Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 54. India Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 58. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 59. Europe Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 60. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 61. Germany Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 62.France Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 69. Egypt Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals in 2025
Figure 75. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 76. Industry Chain Structure of Diagnostic Radiopharmaceuticals
Figure 77. Channels of Distribution
Figure 78. Global Diagnostic Radiopharmaceuticals Sales MarketForecast by Region (2026-2031)
Figure 79. Global Diagnostic Radiopharmaceuticals Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Diagnostic Radiopharmaceuticals Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Diagnostic Radiopharmaceuticals Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Diagnostic Radiopharmaceuticals Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Diagnostic Radiopharmaceuticals Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Diagnostic Radiopharmaceuticals by Country/Region, 2020, 2024 & 2031
2.2 Diagnostic Radiopharmaceuticals Segment by Type
2.2.1 Technetium
2.2.2 Fluorine
2.2.3 Other
2.3 Diagnostic Radiopharmaceuticals Sales by Type
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2020-2025)
2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2020-2025)
2.4 Diagnostic Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals Sales by Application
2.5.1 Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2020-2025)
2.5.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Application (2020-2025)
2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Diagnostic Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Company (2020-2025)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
3.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Company (2020-2025)
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals Product Location Distribution
3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Diagnostic Radiopharmaceuticals Market Size by Geographic Region (2020-2025)
4.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Diagnostic Radiopharmaceuticals Market Size by Country/Region (2020-2025)
4.2.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Country/Region (2020-2025)
4.2.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Country/Region (2020-2025)
4.3 Americas Diagnostic Radiopharmaceuticals Sales Growth
4.4 APAC Diagnostic Radiopharmaceuticals Sales Growth
4.5 Europe Diagnostic Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Diagnostic Radiopharmaceuticals Sales by Country
5.1.1 Americas Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
5.1.2 Americas Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025)
5.2 Americas Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
5.3 Americas Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals Sales by Region
6.1.1 APAC Diagnostic Radiopharmaceuticals Sales by Region (2020-2025)
6.1.2 APAC Diagnostic Radiopharmaceuticals Revenue by Region (2020-2025)
6.2 APAC Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
6.3 APAC Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Diagnostic Radiopharmaceuticals by Country
7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025)
7.2 Europe Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
7.3 Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
10.4 Industry Chain Structure of Diagnostic Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostic Radiopharmaceuticals Distributors
11.3 Diagnostic Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Diagnostic Radiopharmaceuticals Forecast by Region (2026-2031)
12.1.2 Global Diagnostic Radiopharmaceuticals Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Diagnostic Radiopharmaceuticals Forecast by Type (2026-2031)
12.7 Global Diagnostic Radiopharmaceuticals Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Cardinal Health
13.1.1 Cardinal Health Company Information
13.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Main Business Overview
13.1.5 Cardinal Health Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Jubilant Pharma
13.3.1 Jubilant Pharma Company Information
13.3.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jubilant Pharma Main Business Overview
13.3.5 Jubilant Pharma Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 SIEMENS
13.6.1 SIEMENS Company Information
13.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SIEMENS Main Business Overview
13.6.5 SIEMENS Latest Developments
13.7 Lantheus
13.7.1 Lantheus Company Information
13.7.2 Lantheus Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lantheus Main Business Overview
13.7.5 Lantheus Latest Developments
13.8 Bracco Imaging
13.8.1 Bracco Imaging Company Information
13.8.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bracco Imaging Main Business Overview
13.8.5 Bracco Imaging Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 China Isotope & Radiation
13.10.1 China Isotope & Radiation Company Information
13.10.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 China Isotope & Radiation Main Business Overview
13.10.5 China Isotope & Radiation Latest Developments
13.11 Dongcheng
13.11.1 Dongcheng Company Information
13.11.2 Dongcheng Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
13.11.3 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dongcheng Main Business Overview
13.11.5 Dongcheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTechnetium 99
Table 4. Major Players ofFluorine 18
Table 5. Major Players of Other
Table 6. Global Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 7. Global Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue byType (2020-2025) & ($ million)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue Market Share byType (2020-2025)
Table 10. Global Diagnostic Radiopharmaceuticals Sale Price byType (2020-2025) & (US$/Dose)
Table 11. Global Diagnostic Radiopharmaceuticals Sale by Application (2020-2025) & (K Dose)
Table 12. Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2020-2025)
Table 13. Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2025) & ($ million)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
Table 15. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2020-2025) & (US$/Dose)
Table 16. Global Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 18. Global Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 20. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2020-2025) & (US$/Dose)
Table 21. Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 22. Players Diagnostic Radiopharmaceuticals Products Offered
Table 23. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Diagnostic Radiopharmaceuticals Sales by Geographic Region (2020-2025) & (K Dose)
Table 27. Global Diagnostic Radiopharmaceuticals Sales Market Share Geographic Region (2020-2025)
Table 28. Global Diagnostic Radiopharmaceuticals Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Diagnostic Radiopharmaceuticals Sales by Country/Region (2020-2025) & (K Dose)
Table 31. Global Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2020-2025)
Table 32. Global Diagnostic Radiopharmaceuticals Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 35. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Table 36. Americas Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 38. Americas Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 39. APAC Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
Table 40. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. APAC Diagnostic Radiopharmaceuticals Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 43. APAC Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 44. Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 45. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 47. Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 48. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 49. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Diagnostic Radiopharmaceuticals Sales byType (2020-2025) & (K Dose)
Table 51. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Diagnostic Radiopharmaceuticals
Table 53. Key Market Challenges & Risks of Diagnostic Radiopharmaceuticals
Table 54. Key IndustryTrends of Diagnostic Radiopharmaceuticals
Table 55. Diagnostic Radiopharmaceuticals Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Diagnostic Radiopharmaceuticals Distributors List
Table 58. Diagnostic Radiopharmaceuticals Customer List
Table 59. Global Diagnostic Radiopharmaceuticals SalesForecast by Region (2026-2031) & (K Dose)
Table 60. Global Diagnostic Radiopharmaceuticals RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Diagnostic Radiopharmaceuticals SalesForecast by Country (2026-2031) & (K Dose)
Table 62. Americas Diagnostic Radiopharmaceuticals Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Diagnostic Radiopharmaceuticals SalesForecast by Region (2026-2031) & (K Dose)
Table 64. APAC Diagnostic Radiopharmaceuticals Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Diagnostic Radiopharmaceuticals SalesForecast by Country (2026-2031) & (K Dose)
Table 66. Europe Diagnostic Radiopharmaceuticals RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Diagnostic Radiopharmaceuticals SalesForecast by Country (2026-2031) & (K Dose)
Table 68. Middle East & Africa Diagnostic Radiopharmaceuticals RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Diagnostic Radiopharmaceuticals SalesForecast byType (2026-2031) & (K Dose)
Table 70. Global Diagnostic Radiopharmaceuticals RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Diagnostic Radiopharmaceuticals SalesForecast by Application (2026-2031) & (K Dose)
Table 72. Global Diagnostic Radiopharmaceuticals RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Cardinal Health Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 74. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 75. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 76. Cardinal Health Main Business
Table 77. Cardinal Health Latest Developments
Table 78. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 80. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 81. GE Healthcare Main Business
Table 82. GE Healthcare Latest Developments
Table 83. Jubilant Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 85. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 86. Jubilant Pharma Main Business
Table 87. Jubilant Pharma Latest Developments
Table 88. Novartis Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Curium Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 96. Curium Pharma Main Business
Table 97. Curium Pharma Latest Developments
Table 98. SIEMENS Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 100. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 101. SIEMENS Main Business
Table 102. SIEMENS Latest Developments
Table 103. Lantheus Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Lantheus Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 106. Lantheus Main Business
Table 107. Lantheus Latest Developments
Table 108. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 111. Bracco Imaging Main Business
Table 112. Bracco Imaging Latest Developments
Table 113. Eli Lilly Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 115. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 116. Eli Lilly Main Business
Table 117. Eli Lilly Latest Developments
Table 118. China Isotope & Radiation Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 120. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 121. China Isotope & Radiation Main Business
Table 122. China Isotope & Radiation Latest Developments
Table 123. Dongcheng Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Dongcheng Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
Table 125. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 126. Dongcheng Main Business
Table 127. Dongcheng Latest Developments
LIST OFFIGURES
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radiopharmaceuticals Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Diagnostic Radiopharmaceuticals Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2024)
Figure 10. Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTechnetium 99
Figure 12. Product Picture ofFluorine 18
Figure 13. Product Picture of Other
Figure 14. Global Diagnostic Radiopharmaceuticals Sales Market Share byType in 2025
Figure 15. Global Diagnostic Radiopharmaceuticals Revenue Market Share byType (2020-2025)
Figure 16. Diagnostic Radiopharmaceuticals Consumed in Oncology
Figure 17. Global Diagnostic Radiopharmaceuticals Market: Oncology (2020-2025) & (K Dose)
Figure 18. Diagnostic Radiopharmaceuticals Consumed in Cardiology
Figure 19. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2020-2025) & (K Dose)
Figure 20. Diagnostic Radiopharmaceuticals Consumed in Other
Figure 21. Global Diagnostic Radiopharmaceuticals Market: Other (2020-2025) & (K Dose)
Figure 22. Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2024)
Figure 23. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2025
Figure 24. Diagnostic Radiopharmaceuticals Sales by Company in 2025 (K Dose)
Figure 25. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2025
Figure 26. Diagnostic Radiopharmaceuticals Revenue by Company in 2025 ($ millions)
Figure 27. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2025
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 31. Americas Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 32. APAC Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 33. APAC Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 34. Europe Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 35. Europe Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Diagnostic Radiopharmaceuticals Sales 2020-2025 (K Dose)
Figure 37. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 38. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 39. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 40. Americas Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 41. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 42. United States Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2025
Figure 47. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Figure 48. APAC Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 49. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 50. China Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 54. India Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 58. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 59. Europe Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 60. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 61. Germany Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 62.France Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 69. Egypt Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Diagnostic Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals in 2025
Figure 75. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 76. Industry Chain Structure of Diagnostic Radiopharmaceuticals
Figure 77. Channels of Distribution
Figure 78. Global Diagnostic Radiopharmaceuticals Sales MarketForecast by Region (2026-2031)
Figure 79. Global Diagnostic Radiopharmaceuticals Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Diagnostic Radiopharmaceuticals Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Diagnostic Radiopharmaceuticals Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Diagnostic Radiopharmaceuticals Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Diagnostic Radiopharmaceuticals Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Metabolism Drugs Market Growth 2025-2031
US$ 3,660.00
March 2025
101 pages
Global Tigecycline Drug Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
104 pages
Global Sickle Cell Disease Diagnosis Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
98 pages
